We are live on
!
Find out more
CC
Corton Capital Portfolio holdings
AUM
$40.7M
1-Year Est. Return
52.32%
This Fund
S&P 500
This Quarter
Est. Return
+15.1%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
+$68.7M
(+48%)
Cap. Flow
+$47.4M
Cap. Flow
% of AUM
22.27%
Top 10 Holdings %
Top 10 Hldgs %
28.96%
Holding
538
New
222
Increased
132
Reduced
66
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.35M |
| 2 |
NextEra Energy
NEE
|
+$1.28M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1.19M |
| 4 |
MGM Resorts International
MGM
|
+$1.1M |
| 5 |
H&R Block
HRB
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.04M |
| 2 |
KLA
KLAC
|
+$843K |
| 3 |
ZIM Integrated Shipping Services
ZIM
|
+$790K |
| 4 |
Vistra
VST
|
+$734K |
| 5 |
Cheniere Energy
LNG
|
+$729K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.1% |
| 2 | Healthcare | 12.95% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Financials | 8.23% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RC
376
Ready Capital
RC
$261M
| $139K | 0.07% |
+12,357
| New | +$130K |
|
|
RNAM
377
DELISTED
Avidity Biosciences
RNAM
| $137K | 0.06% |
+12,356
| New | +$155K |
|
378
Paysafe
PSFE
$463M
| $135K | 0.06% |
+13,351
| New | +$169K |
|
379
Vivid Seats
SEAT
$88.7M
| $134K | 0.06% |
+845
| New | +$132K |
|
380
Similarweb
SMWB
$630M
| $134K | 0.06% |
+20,372
| New | +$124K |
|
381
Allogene Therapeutics
ALLO
$573M
| $132K | 0.06% |
26,585
-6,565
| -20% | -$35.5K |
|
|
TRHC
382
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $131K | 0.06% |
+15,916
| New | +$95.2K |
|
|
SLCA
383
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $131K | 0.06% |
+10,818
| New | +$134K |
|
|
TBCH
384
Turtle Beach Corp
TBCH
$258M
| $130K | 0.06% |
11,164
-3,327
| -23% | -$37.1K |
|
385
JetBlue
JBLU
$2.23B
| $129K | 0.06% |
14,602
-14,259
| -49% | -$104K |
|
386
Snap
SNAP
$8.02B
| $126K | 0.06% |
+10,636
| New | +$107K |
|
387
Rayonier Advanced Materials
RYAM
$591M
| $124K | 0.06% |
28,972
-1,061
| -4% | -$5.02K |
|
388
CareDx
CDNA
$1.85B
| $123K | 0.06% |
+14,527
| New | +$121K |
|
|
SWI
389
DELISTED
SolarWinds Corporation Common Stock
SWI
| $122K | 0.06% |
11,918
-412
| -3% | -$3.75K |
|
390
SunCoke Energy
SXC
$779M
| $120K | 0.06% |
15,296
-565
| -4% | -$4.43K |
|
391
NextDecade
NEXT
$1.63B
| $119K | 0.06% |
+14,552
| New | +$89.3K |
|
|
DSKE
392
DELISTED
Daseke, Inc. Common Stock
DSKE
| $119K | 0.06% |
+16,651
| New | +$117K |
|
393
Editas Medicine
EDIT
$402M
| $113K | 0.05% |
+13,775
| New | +$120K |
|
|
PACW
394
DELISTED
PacWest Bancorp
PACW
| $112K | 0.05% |
+13,795
| New | +$111K |
|
|
SCU
395
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $112K | 0.05% |
+12,662
| New | +$110K |
|
396
Zeta Global
ZETA
$5.46B
| $110K | 0.05% |
+12,869
| New | +$118K |
|
397
Design Therapeutics
DSGN
$741M
| $109K | 0.05% |
+17,323
| New | +$106K |
|
|
MRSN
398
DELISTED
Mersana Therapeutics
MRSN
| $108K | 0.05% |
1,317
+114
| +9% | +$16.7K |
|
399
GoodRx Holdings
GDRX
$1.06B
| $106K | 0.05% |
+19,137
| New | +$103K |
|
400
FIGS
FIGS
$1.73B
| $104K | 0.05% |
+12,567
| New | +$95.6K |
|
Similar funds
NLVP
BAM
MAM
AM
WCPI
OC
HCM
PI
Corton Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Corton Capital held 538 positions worth $213M, up 48% from $144M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Corton Capital deployed $47.4M of net new capital in Q2 2023, opening 222 new positions and adding to 132 existing holdings. Its largest new stake was NVIDIA: 40,640 shares worth $1.72M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was DraftKings, an estimated $655K trimmed.
- Corton Capital's largest Q2 2023 buy was NVIDIA: 40,640 shares worth $1.72M.
- Corton Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $786K increase.
- Corton Capital's biggest Q2 2023 reduction was DraftKings, cutting an estimated $655K.
- Corton Capital fully exited Lam Research in Q2 2023, selling an estimated $1.04M.
- Corton Capital's ten largest holdings make up 29% of its $213M portfolio in Q2 2023.
- Corton Capital opened 222 new positions and closed 117 in Q2 2023.
- Corton Capital's portfolio value rose 48% quarter-over-quarter to $213M.
Based on Corton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.